Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

An Important Drug Target Discovered for Triple-Negative Breast Cancer Treatment

An Important Drug Target Discovered for Triple-Negative Breast Cancer Treatment

Following the 2016 Nobel Prize in Physiology or Medicine, research accelerated into cellular starvation, an important step in autophagy . Experiments particularly examined amino acids’ importance in pathways critical to cancer development.

In November 2016, the respected genetics journal Oncogenepublished research showing that blocking uptake of the oxidized form of cysteine, cystine (Cystine) , could kill treatment-resistant triple-negative breast cancer cells.

One of cancer’s 10 hallmarks is changing energy metabolism to enable rapid proliferation. Cancer cells use metabolic molecules such as amino acids, glucose and fat. Proteins carry out vital bodily functions and are formed from amino acids. The body synthesizes some amino acids, while others must be obtained externally.

Recent research examined cancer cells’ dependence on particular amino acids for growth. This study cultured breast cancer cells in media containing different amino acids to identify which supported proliferation.

According to the Research Results:

  • Triple-negative breast cancer cells required cystine to proliferate. Cells deprived of it began dying.
  • An important drug target was discovered. To spread to other tissues and organs, cancer cells must undergo epithelial–mesenchymal transition . Triple-negative breast cancer cells making this transition required cystine for basic vital functions. These dependent cells died rapidly without it.

What Does This Study Mean Clinically?

  • Triple-negative breast cancer accounts for 10-20 percent of breast cancers and has very limited treatment options. New drugs are needed. Developing cystine-targeting molecules following this research could enable more effective treatment.
  • Metastasis remains one of cancer science’s darkest areas. Responsible for 90 percent of cancer deaths, it is the target of this study, which also guides discovery of new biomarkers .

Further Reading for Interested Readers

Amino Acids: Amino acids are proteins’ basic building blocks. Chemically, an amino acid contains both “amine” and “carboxyl” groups. Short polymer chains formed by linking amino acids are “peptides,” and long chains “polypeptides” or proteins . Inside cells, ribosomes use mRNA templates to link amino acids and synthesize proteins. This is called translation (translation). Not every amino acid must occur in every protein, nor in equal amounts. Proteins may also contain very different amino acids. In our body, amino acids form through subsequent “modifications” of polypeptides made from 20 basic amino acids.

protein building blocks amino acids essential and nonessential infographic

Sources

X Tang, C-K Ding et al.,
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.
Oncogene, 2016

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

An Important Drug Target Discovered for Triple-Negative Breast Cancer Treatment

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy